• TechBio Survey Shows a Mixed Industry Outlook, Claude Gaining Ground, More Machine Learning

    Bio-IT World | The Bits in Bio Slack-first community has released its fourth annual State of TechBio survey results. Year over year findings include a jump in Claude usage, an increase in daily machine learning work, and a serious cooling of the “Very bullish" sentiment across the broader biotech market.

    Jan 9, 2026
  • Systems Biology Map for Advancing the Translation of Extracellular Vesicles

    Bio-IT World | Extracellular vesicles (EVs) are the master communicators of multicellular life, key in orchestrating the complex signaling networks that define physiology. A new multiomics study has now revealed their molecular cargo via EVMap, a high-resolution blueprint of the proteins and lipids in human circulating EVs providing a practical pathway forward across basic, translational and clinical applications.

    Jan 7, 2026
  • Insilico Medicine’s IPO, Servier Pharma Deal

    Bio-IT World | On December 30, Insilico Medicine successfully listed on the Hong Kong Stock Exchange. This initial public offering (IPO) raised a total of HKD 2.277 billion ($292 billion), achieving the largest biotech IPO in Hong Kong in 2025.

    Jan 6, 2026
  • Trendspotting: Artificial Intelligence, Impact of Global Policies, Data Harmonization

    Bio-IT World | To kick off 2026, we spoke with industry experts and leaders in the Bio-IT World community about what they expect and look forward to in the new year. Here are the full trends and predictions, including more on AI, drug development, global policies, cancer treatments, and more.

    Jan 6, 2026
  • Top Stories of 2025: AI for Research, Innovative Practices, Digital Twins

    Bio-IT World | In the Bio-IT World year, focus continues to be paid to pharma’s research choices and the latest in sequencing technologies. AI models for protein structure prediction have had a good year, and natural materials, psilocybin in particular, have garnered attention.

    Dec 29, 2025
  • Follow the Money: Molecular Glue Degrader, Physical AI Scientists, TNF Programs

    Bio-IT World | TRIANA will continue development of their molecular glue degrader to clinical proof; Medra’s Physical AI autonomously allows scientists to adapt workflows through natural-language instructions; PsiThera will advance their Tumor Necrosis Factor superfamily preclinical programs; and more.

    Dec 23, 2025
  • Thermo Fisher’s New Devices, LabGenius, Sanofi Collaboration, Singapore-MIT Alliance Launches New Project

    Bio-IT World | Thermo Fisher Scientific has introduced the Thermo Scientific X and S Series Centrifuges; LabGenius has entered a second collaboration with Sanofi; the Singapore-MIT Alliance for Research and Technology has launched a new collaborative research project; and more.

    Dec 22, 2025